Malaria resistance: artificial induction with a partially purified plasmodial fraction

Science (New York, N.Y.)
|May 29, 1970
PubMed

Insights

Researchers developed a Plasmodium berghei vaccine from mouse red blood cells. This erythrocyte-free fraction protected mice against malaria infection, preventing disease and death.

Area of Science:

  • Malariology
  • Immunology
  • Parasitology

Background:

  • Malaria remains a significant global health challenge.
  • Effective vaccines are crucial for malaria control and eradication efforts.

Purpose of the Study:

  • To isolate and characterize a Plasmodium berghei fraction with potential vaccine properties.
  • To evaluate the efficacy of this fraction in preventing malaria in a mouse model.

Main Methods:

  • Plasmodium berghei were isolated from mouse erythrocytes using a French pressure cell.
  • Isolated organisms were washed, disintegrated, and fractionated via Sephadex (G-200) chromatography.
  • The void-volume eluate, an erythrocyte-free fraction, was collected for further analysis.

Main Results:

  • An erythrocyte-free Plasmodium berghei fraction was successfully isolated.
  • This fraction demonstrated significant vaccine-like activity in mice.
  • Protected mice showed no parasitemia, anemia, or mortality upon challenge with live Plasmodium berghei.

Conclusions:

  • An erythrocyte-free fraction of Plasmodium berghei possesses potent malaria vaccine potential.
  • This finding opens avenues for developing novel malaria vaccines.
  • Further research is warranted to explore the immunogenic components and mechanisms of this protective fraction.